These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1207 related articles for article (PubMed ID: 12483210)
1. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Kotenko SV; Gallagher G; Baurin VV; Lewis-Antes A; Shen M; Shah NK; Langer JA; Sheikh F; Dickensheets H; Donnelly RP Nat Immunol; 2003 Jan; 4(1):69-77. PubMed ID: 12483210 [TBL] [Abstract][Full Text] [Related]
2. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. Donnelly RP; Sheikh F; Kotenko SV; Dickensheets H J Leukoc Biol; 2004 Aug; 76(2):314-21. PubMed ID: 15123776 [TBL] [Abstract][Full Text] [Related]
3. IL-28, IL-29 and their class II cytokine receptor IL-28R. Sheppard P; Kindsvogel W; Xu W; Henderson K; Schlutsmeyer S; Whitmore TE; Kuestner R; Garrigues U; Birks C; Roraback J; Ostrander C; Dong D; Shin J; Presnell S; Fox B; Haldeman B; Cooper E; Taft D; Gilbert T; Grant FJ; Tackett M; Krivan W; McKnight G; Clegg C; Foster D; Klucher KM Nat Immunol; 2003 Jan; 4(1):63-8. PubMed ID: 12469119 [TBL] [Abstract][Full Text] [Related]
4. Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses. Li M; Liu X; Zhou Y; Su SB J Leukoc Biol; 2009 Jul; 86(1):23-32. PubMed ID: 19304895 [TBL] [Abstract][Full Text] [Related]
6. Lambda-Interferons Inhibit Herpes Simplex Virus Type 2 Replication in Human Cervical Epithelial Cells by Activating the JAK/STAT Pathway. Li Z; Lu X; Zhu Y; Cheng P; Liu S; Zhang Y; Tang J; Yang S; Zhou L Jpn J Infect Dis; 2017 Jul; 70(4):416-422. PubMed ID: 28250263 [TBL] [Abstract][Full Text] [Related]
7. Biological activity of interleukins-28 and -29: comparison with type I interferons. Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585 [TBL] [Abstract][Full Text] [Related]
8. Type III Interferons in Viral Infection and Antiviral Immunity. Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714 [TBL] [Abstract][Full Text] [Related]
9. SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Brand S; Zitzmann K; Dambacher J; Beigel F; Olszak T; Vlotides G; Eichhorst ST; Göke B; Diepolder H; Auernhammer CJ Biochem Biophys Res Commun; 2005 Jun; 331(2):543-8. PubMed ID: 15850793 [TBL] [Abstract][Full Text] [Related]
10. Identification and establishment of type IV interferon and the characterization of interferon-υ including its class II cytokine receptors IFN-υR1 and IL-10R2. Chen SN; Gan Z; Hou J; Yang YC; Huang L; Huang B; Wang S; Nie P Nat Commun; 2022 Feb; 13(1):999. PubMed ID: 35194032 [TBL] [Abstract][Full Text] [Related]
11. Interferon-lambda: a new addition to an old family. Donnelly RP; Kotenko SV J Interferon Cytokine Res; 2010 Aug; 30(8):555-64. PubMed ID: 20712453 [TBL] [Abstract][Full Text] [Related]
12. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. Bartlett NW; Buttigieg K; Kotenko SV; Smith GL J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836 [TBL] [Abstract][Full Text] [Related]
13. Novel type III interferons produce anti-tumor effects through multiple functions. Li Q; Kawamura K; Tada Y; Shimada H; Hiroshima K; Tagawa M Front Biosci (Landmark Ed); 2013 Jun; 18(3):909-18. PubMed ID: 23747856 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of canine interferon-lambda. Fan W; Xu L; Ren L; Qu H; Li J; Liang J; Liu W; Yang L; Luo T J Interferon Cytokine Res; 2014 Nov; 34(11):848-57. PubMed ID: 24950142 [TBL] [Abstract][Full Text] [Related]
15. Human interferon-lambda3 is a potent member of the type III interferon family. Dellgren C; Gad HH; Hamming OJ; Melchjorsen J; Hartmann R Genes Immun; 2009 Mar; 10(2):125-31. PubMed ID: 18987645 [TBL] [Abstract][Full Text] [Related]
16. [Interferons: between structure and function]. Bandurska K; Król I; Myga-Nowak M Postepy Hig Med Dosw (Online); 2014 May; 68():428-40. PubMed ID: 24864095 [TBL] [Abstract][Full Text] [Related]
17. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis. Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878 [TBL] [Abstract][Full Text] [Related]
18. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3. Yang L; Luo Y; Wei J; He S Int J Mol Med; 2010 May; 25(5):807-12. PubMed ID: 20372826 [TBL] [Abstract][Full Text] [Related]
19. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. Dumoutier L; Tounsi A; Michiels T; Sommereyns C; Kotenko SV; Renauld JC J Biol Chem; 2004 Jul; 279(31):32269-74. PubMed ID: 15166220 [TBL] [Abstract][Full Text] [Related]
20. Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages. Wang Y; Li J; Wang X; Zhou Y; Zhang T; Ho W J Interferon Cytokine Res; 2015 Mar; 35(3):213-21. PubMed ID: 25268605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]